Gülşah BAYRAKTAR
Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Eczacılık, Temel Bilimler, Temel Eczacılık Bilimleri, Yaşam Bilimleri, Meslek Bilimleri, Farmasötik Kimya, Kimya, Biyokimya, Alkoloidler
Yayınlar
- Shaping Future Medicinal Chemists: Perspectives from European Schools of Pharmacy within the GP2A Network (2025)
- Biological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms (2024)
- Recent Molecular Targets and their Ligands for the Treatment of Alzheimer Disease (2024)
- Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies (2024)
- Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition (2023)
- Fused Pyridine Derivatives: Synthesis and Biological Activities (2022)
- Toward New Antileishmanial Compounds: Molecular Targets for Leishmaniasis Treatment (2022)
- Toward New Antileishmanial Compounds: Molecular Targets for Leishmaniasis Treatment (2021)
- 29th Annual GP2A Medicinal Chemistry Conference (2021)
- Design, Synthesis and Bioactivity Studies of Novel Triazolopyrimidinone Compounds (2021)
- Potential Anti-Alzheimer Tacrine-Donepezil Hybrids with MTDL Profile (2020)
- Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds (2020)
- A Fusing Strategy Application: Towards Potent ChE Inhibitors with MTDL Profile (2019)
- Studies on novel Tacrine-Donepezil hybrids with potent MTDL profile (2019)
- A Merging Strategy Application: Tacrine-Benzylidenehydrazone Hybrids as Potent ChE Inhibitors with Metal Binding and Neuroprotective Properties (2018)
- Design, synthesis and biological activity studies on novel Tacrine-donepezile hybrides as MTDL against Alzheimer's Disease (2018)
- NEW HETEROCYCLIC COMPOUNDS WITH ANTILEISHMANIAL ACTIVITY: DESIGN, SYNTHESIS, BIOACTIVITY AND MOLECULAR MODELLING STUDIES (2018)
- Design, synthesis and biological activity studies on novel tacrine-donepezil hybrides as MTDL against Alzheimer’s disease (2018)
- Design and synthesis of 1,4-dihydropyridine derivatives aspotential cholinesterase inhibitorswith H2S releasing group (2018)
- REVERSAL ANTIBIOTIC RESISTANCE with MTDL STRATEGIES: NMP (NAPHTHYLMETHYLPIPERAZINE) HYBRIDS (2018)
- Synthesis and Bilogical Evaluation of 9-Benzylidenehydrazino-1,2,3,4-tetrahydroacridine Derivatives (2017)
- SYNTHESIS AND BIOLOGICAL EVALUATION OF 9-BENZYLIDENE HYDRAZINO-1,2,3,4-TETRAHYDROACRIDINE DERIVATIVES AS POTENTIAL ACETYLCHOLINESTERASE INHIBITORS (2017)
- Properties of elastic fabrics with treated and untreated Co/PBT yarns in weft direction (2017)
- Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors (2016)
- Synthesis Characterization and Bioactivity Studies of Novel Thiazolopyrimidine Derivatives as Potential Antileishmanial PTR1 Enzyme Inhibitors (2015)
- Synthesis and Biological Evaluation of Pyridinium Hydrazone Derivatives as Potential Antileismanial PTR1Inhibitors (2015)
- SYNTHESIS AND BIOLOGICAL ACTIVITY STUDIES ON ACETOPHENONE HYDRAZONE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS (2015)
- Synthesis and biological evaluation of pyridinium-hydrazone derivatives as potential antileishmanial PTR1 inhibitors (2015)
- 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood–brain barrier (2013)